Epidemiology of primary rubella infection in the Central African Republic: data from measles surveillance, 2007-2014

被引:3
作者
Farra, Alain [1 ]
Pagonendji, Marilou [1 ]
Manikariza, Alexandre [2 ]
Rawago, Dieubeni [2 ]
Ouambita-Mabo, Rock [3 ]
Guifara, Gilbert [4 ]
Gouandjika-Vasilache, Ionela [1 ]
机构
[1] Inst Pasteur, Enter Viruses & Measles Lab, Bangui BP 923, Bangui, Cent Afr Republ
[2] Inst Pasteur, Epidemiol Unit, Bangui, Cent Afr Republ
[3] Minist Hlth, Expanded Programme Immunizat, Bangui, Cent Afr Republ
[4] WHO, Epidemiol Surveillance Unit, Bangui, Cent Afr Republ
关键词
Rubella; IgM; Sero-prevalence; Central African Republic; PARVOVIRUS B19; IGM; SEROPREVALENCE; ANTIBODIES; CHILDREN;
D O I
10.1186/s12879-016-1842-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Although rubella is generally considered a benign childhood disease, infection of a pregnant woman can cause foetal congenital rubella syndrome, which results in embryo-foetal disease and malformations. The syndrome is still a public health problem in developing countries where the vaccine has not yet been introduced, such as the Central African Republic (CAR). The aim of the study reported here was to define the epidemiology of primary rubella infection, in order to determine its effect on morbidity rates in the country. Methods: Data derived from epidemiological surveillance of measles and rubella were analysed retrospectively between 1 January 2007 and 31 December 2014. The database includes cases of suspected measles, according to the WHO clinical case definition. In this algorithm, samples that are negative or doubtful by ELISA for measles (presence of immunoglobulin M) are tested in another ELISA for detection of rubella-specific IgM. Descriptive analyses were conducted for socio-demographic characteristics, including age, sex and health region, for patients tested for rubella. Results: Of the sera tested for rubella, 30.2 % (425/1409) were positive, 62.3 % (878/1409) were negative, and 7.5 % (106/1409) were doubtful. Among the 425 positive cases, 213 (50.1 %) were female and 212 (40.9 %) were male with a sex ratio of 1.03. The mean age was 8 years (range, 6-37 years). The highest prevalence (47.3 %; 116/425) was seen in 2007 and the lowest (8.9 %; 11/425) in 2012. Primary infections were always more frequent during the first 3 months of the year, with a peak at the same time, between January and February which is the hottest period of the year in the CAR. In both sexes, rubella IgM was rarely found before the age of 1 year (0.5 %; 2/425). The highest rate (43.5 %; 185/425) was observed at ages 5-9 years; however, at least 8 % (18/213) of girls aged 15 or more had primary infections. Conclusions: Sentinel sites for surveillance of congenital rubella syndrome are urgently needed, and introduction of vaccination against rubella in the Expanded Programme of Immunization should be considered, to ensure immunization of girls of reproductive age.
引用
收藏
页数:6
相关论文
共 25 条
  • [1] [Anonymous], 1999, Can Commun Dis Rep, V25, P201
  • [2] ASSAAD F, 1985, REV INFECT DIS, V7, pS29
  • [3] Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia
    Bartoloni, A
    Bartalesi, F
    Roselli, M
    Mantella, A
    Dini, F
    Carballo, ES
    Barron, VP
    Paradisi, F
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2002, 7 (06) : 512 - 517
  • [4] Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe
    Chimhuya, Simbarashe
    Manangazira, Portia
    Mukaratirwa, Arnold
    Nziramasanga, Pasipanodya
    Berejena, Chipo
    Shonhai, Annie
    Kamupota, Mary
    Gerede, Regina
    Munyoro, Mary
    Mangwanya, Douglas
    Tapfumaneyi, Christopher
    Byabamazima, Charles
    Shibeshi, Eshetu Messeret
    Nathoo, Kusum Jackison
    [J]. BMC PUBLIC HEALTH, 2015, 15
  • [5] COHEN BJ, 1985, LANCET, V2, P662
  • [6] False-positive results of an enzyme immunoassay for rubella IgM in a case of measles
    Donovan, SM
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) : 271 - 272
  • [7] Fenner F, 1998, Bull World Health Organ, V76 Suppl 2, P68
  • [8] Rubella Epidemiology in Africa in the Prevaccine Era, 2002-2009
    Goodson, James L.
    Masresha, Balcha
    Dosseh, Annick
    Byabamazima, Charles
    Nshimirimana, Deogratias
    Cochi, Stephen
    Reef, Susan
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 204 : S215 - S225
  • [9] Hinman AR, 2002, B WORLD HEALTH ORGAN, V80, P264
  • [10] Assessment of the specificity of a commercial human parvovirus B19 IgM assay
    Jensen, IP
    Vestergaard, BF
    [J]. CLINICAL AND DIAGNOSTIC VIROLOGY, 1997, 7 (03): : 133 - 137